David Giljohann, CEO of IIN-startup Exicure, discusses SNAs and immunotherapy: “the new new in modern medical miracles.”

EVANSTON, Ill.—David Giljohann, Northwestern professor, former Ryan Fellow, and CEO of IIN-startup Exicure, discusses spherical nucleic acids (SNAs) and immunotherapy, “the new new in modern medical miracles,” on the John Batchelor Show.

The International Institute for Nanotechnology at Northwestern University is an umbrella organization that represents and unites more than $1 billion in nanotechnology research, education and supporting infrastructure.